Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
21.5M
-
Number of holders
-
136
-
Total 13F shares, excl. options
-
14.5M
-
Shares change
-
+1.23M
-
Total reported value, excl. options
-
$525M
-
Value change
-
+$40.3M
-
Put/Call ratio
-
1.12
-
Number of buys
-
89
-
Number of sells
-
-49
-
Price
-
$36.14
Significant Holders of ENANTA PHARMACEUTICALS INC - Common Stock (ENTA) as of Q3 2015
158 filings reported holding ENTA - ENANTA PHARMACEUTICALS INC - Common Stock as of Q3 2015.
ENANTA PHARMACEUTICALS INC - Common Stock (ENTA) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.5M shares
of 21.5M outstanding shares and own 67.71% of the company stock.
Largest 10 shareholders include Apex Capital Management (1.22M shares), BlackRock Fund Advisors (1.15M shares), EAGLE ASSET MANAGEMENT INC (1.05M shares), FMR LLC (953K shares), STATE STREET CORP (896K shares), ACADIAN ASSET MANAGEMENT LLC (736K shares), Krensavage Asset Management, LLC (730K shares), Invesco Ltd. (640K shares), VANGUARD GROUP INC (574K shares), and Consonance Capital Management LP (571K shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.